- Home
- IMNM vs GLDD Comparison
IMNM vs GLDD Comparison
Compare IMNM & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- GLDD
- Stock Information
- Founded
- IMNM 2006
- GLDD 1890
- Country
- IMNM United States
- GLDD United States
- Employees
- IMNM N/A
- GLDD N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- GLDD Military/Government/Technical
- Sector
- IMNM Health Care
- GLDD Industrials
- Exchange
- IMNM Nasdaq
- GLDD Nasdaq
- Market Cap
- IMNM 747.7M
- GLDD 829.6M
- IPO Year
- IMNM 2020
- GLDD 2006
- Fundamental
- Price
- IMNM $12.01
- GLDD $11.87
- Analyst Decision
- IMNM Strong Buy
- GLDD Buy
- Analyst Count
- IMNM 5
- GLDD 1
- Target Price
- IMNM $28.60
- GLDD $14.00
- AVG Volume (30 Days)
- IMNM 803.1K
- GLDD 409.1K
- Earning Date
- IMNM 11-13-2024
- GLDD 11-05-2024
- Dividend Yield
- IMNM N/A
- GLDD N/A
- EPS Growth
- IMNM N/A
- GLDD N/A
- EPS
- IMNM N/A
- GLDD 0.87
- Revenue
- IMNM $10,129,000.00
- GLDD $741,648,000.00
- Revenue This Year
- IMNM N/A
- GLDD $33.01
- Revenue Next Year
- IMNM N/A
- GLDD $6.88
- P/E Ratio
- IMNM N/A
- GLDD $13.52
- Revenue Growth
- IMNM N/A
- GLDD 33.74
- 52 Week Low
- IMNM $7.76
- GLDD $6.55
- 52 Week High
- IMNM $30.96
- GLDD $12.89
- Technical
- Relative Strength Index (RSI)
- IMNM 43.70
- GLDD 43.17
- Support Level
- IMNM $12.99
- GLDD $11.70
- Resistance Level
- IMNM $15.13
- GLDD $12.14
- Average True Range (ATR)
- IMNM 0.93
- GLDD 0.31
- MACD
- IMNM -0.16
- GLDD -0.11
- Stochastic Oscillator
- IMNM 3.79
- GLDD 21.01
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.